News
SDMHF
203.75
NaN%
--
Sartorius Stedim Biotech (0RG8) was upgraded to a Buy Rating at Goldman Sachs
TipRanks · 03/30 10:45
Sartorius Stedim upgraded to Buy from Hold at Kepler Cheuvreux
TipRanks · 03/18 08:50
J.P. Morgan Sticks to Their Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 03/18 07:25
Sartorius Stedim Biotech (0RG8) Receives a Buy from RBC Capital
TipRanks · 03/18 06:56
Goldman Sachs Sticks to Their Hold Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 03/17 10:26
Jefferies Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
TipRanks · 03/17 09:58
Barclays Remains a Buy on Sartorius Stedim Biotech (0RG8)
TipRanks · 03/17 09:45
Sartorius Issues New Mid-term Financial Targets
NASDAQ · 03/17 06:44
Sartorius Stedim Biotech (0RG8) Gets a Buy from Bernstein
TipRanks · 03/16 12:56
Sartorius Stedim Biotech (0RG8) Gets a Hold from Kepler Capital
TipRanks · 03/14 01:40
Sartorius Stedim upgraded to Outperform from Sector Perform at RBC Capital
TipRanks · 03/06 09:30
Positive Report for Sartorius Stedim Biotech (0RG8) from RBC Capital
TipRanks · 03/06 08:05
Invesco International Growth Fund Q4 2025 Portfolio Update
Seeking Alpha · 02/16 16:43
Sartorius Stedim Biotech (0RG8) Receives a Hold from Kepler Capital
TipRanks · 02/05 07:28
Sartorius Stedim Biotech (0RG8) Receives a Buy from Barclays
TipRanks · 02/05 01:46
RBC Capital Sticks to Its Hold Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 02/05 01:45
Sartorius Stedim Biotech FY25 Results Climb; Sees Growth In FY26, Beyond
NASDAQ · 02/03 07:07
Sartorius Stedim Biotech S.A. Non-GAAP EPS of €4.40, revenue of €2.97B; initates FY26 outlook
Seeking Alpha · 02/03 06:29
UBS Keeps Their Hold Rating on Sartorius Stedim Biotech (0RG8)
TipRanks · 02/02 09:26
Bernstein Reaffirms Their Buy Rating on Sartorius Stedim Biotech (0RG8)
TipRanks · 01/13 09:55
More
Webull provides a variety of real-time SDMHF stock news. You can receive the latest news about Sartorius Stedim through multiple platforms. This information may help you make smarter investment decisions.
About SDMHF
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.